Clinical Trial Update: Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic ablative radiotherapy for hepatocellular carcinoma with major portal vein invasion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Korea Cancer Center Hospital | Conditions: Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | Phase 2 | Status: COMPLETED